CHANGING RED BLOOD CELL (RBC) AND PLATELET TRANSFUSION NEEDS IN MYELODYSPLASTIC SYNDROMES (MDS): A 15-YEAR AUSTRALIAN POPULATION DATA-LINKAGE STUDY

被引：0
|
作者：
Mo, Allison [1 ,2 ,3 ,4 ]
Wood, Erica M. [1 ,2 ]
Shortt, Jake [2 ,5 ]
Goswami, Ani [6 ]
Quek, Christine [6 ]
McQuilten, Zoe K. [1 ,2 ]
机构：
[1] Monash Univ, Transfus Res Unit, Melbourne, Vic, Australia
[2] Monash Hlth, Dept Haematol, Clayton, Vic, Australia
[3] Austin Pathol, Heidelberg, Vic, Australia
[4] Dept Haematol, Heidelberg, Vic, Australia
[5] Monash Univ, Sch Clin Sci, Monash Hlth, Clayton, Vic, Australia
[6] Western & Cent Melbourne Integrated Canc Serv, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
8.09
引用
收藏
页数：1
相关论文
共 19 条
  • [1] Large Population Dataset Linkage to Understand Evolving Practice in Red Cell and Platelet Transfusion and Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS): A 15-Year Study
    Mo, Allison
    Shortt, Jake
    Wood, Erica M.
    McQuilten, Zoe K.
    BLOOD, 2021, 138
  • [2] HIGH RED BLOOD CELL (RBC) AND PLATELET TRANSFUSION BURDEN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Mo, A.
    Wood, E.
    Shortt, J.
    McQuilten, Z.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 13 - 14
  • [3] Incidence of preexisting organ damage in myelodysplastic syndromes (MDS) patients without a history of chronic red blood cell (RBC) transfusion
    Wong, L.
    Go, L.
    Koss, W.
    Song, J.
    Wajima, T.
    LEUKEMIA RESEARCH, 2009, 33 : S99 - S99
  • [4] Persistent Red Blood Cell (RBC) Transfusion Is Associated with Increased Mortality Risk in Transfusion-Dependent (TD) Patients with Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS plus )
    Buckstein, Rena
    Zhu, Nancy
    Keating, Mary-Margaret
    Leber, Brian
    Chodirker, Lisa
    Sabloff, Mitchell
    Cristou, Grace
    Leitch, Heather A.
    St Hilaire, Eve
    Finn, Nicholas
    Yee, Karen W. L.
    Elemary, Mohamed
    Banerji, Versha
    Lenis, Martha
    Kirubananthaan, Aksharh
    Liu, Fei Fei
    Tang, Derek
    Westcott, Chris
    Huang, Vicky Wei-Hsuen
    Wang, Di
    Cameron, Chris
    Morison, Jessica
    Spin, Paul
    Mamedov, Alexandre
    BLOOD, 2019, 134
  • [5] Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myelodysplasies (GFM)
    Jouzier, Claire
    Cherait, Amina
    Cony-Makhoul, Pascale
    Hamel, Jean-Francois
    Veloso, Melanie
    Thepot, Sylvain
    Cluzeau, Thomas
    Stamatoullas, Aspasia
    Garnier, Alice
    Guerci-Bresler, Agnes
    Dimicoli-Salazar, Sophie
    Pica, Gian Matteo
    Cheze, Stephane
    Santana, Clemence
    Chermat, Fatiha
    Fenaux, Pierre
    Park, Sophie
    TRANSFUSION, 2022, 62 (05) : 961 - 973
  • [6] Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myelodysplasies (GFM)
    Jouzier, Claire
    Cherait, Amina
    Cony-Makhoul, Pascale
    Thepot, Sylvain
    Cluzeau, Thomas
    Bastard, Aspasia Stamatoulas
    Peterlin, Pierre
    Bresler, Agnes Guerci
    Dimicoli-Salazar, Sophie
    Pica, Gian-Matteo
    Cheze, Stephane
    Santana, Clemence
    Chermat, Fatiha
    Fenaux, Pierre
    Park, Sophie
    BLOOD, 2020, 136
  • [7] Impact of Timing of Achievement of Red Blood Cell-Transfusion Independence (RBC-TI) on Clinical Outcomes and Resource Utilization in Lower-Risk Myelodysplastic Syndromes (LR-MDS)
    Coughlan, Anna
    Klijn, Sven L.
    Xiao, Hong
    White, Benjamin
    Litkiewicz, Michal
    Kadambi, Ananth
    Sichevaya, Alina
    Hnoosh, Ahmed
    Miteva, Dimana
    Yucel, Aylin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S351 - S351
  • [8] Overall Survival (OS), Clinical Benefit, and Durable Red Blood Cell (RBC) Transfusion Independence (TI) With Imetelstat in the IMerge Phase 3 Trial of RBC-Transfusion Dependent (TD) Lower-Risk Myelodysplastic Syndromes (LR-MDS)
    Santini, Valeria
    Komrokji, Rami S.
    Sekeres, Mikkael A.
    Savona, Michael Robert
    Fenaux, Pierre
    Madanat, Yazan F.
    Oliva, Esther
    Buckstein, Rena
    Jonasova, Anna
    Germing, Ulrich
    Mittelman, Moshe
    Thepot, Sylvain
    Riggs, Jennifer
    Dougherty, Souria
    Berry, Tymara
    Navada, Shyamala
    Xia, Qi
    Sun, Libo
    Zeidan, Amer M.
    Platzbecker, Uwe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S386 - S387
  • [9] Benefit of Continuing Luspatercept Therapy in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Who Did Not Achieve Red Blood Cell Transfusion Independence (RBC-TI) by Week 25 in the MEDALIST Study
    Platzbecker, Uwe
    Germing, Ulrich
    Fenaux, Pierre
    Buckstein, Rena
    Santini, Valeria
    Diez-Campelo, Maria
    Tang, Derek
    Ito, Rodrigo
    Fabre, Shannon
    Mantovani, Emily
    Zhang, George
    Ha, Xianwei
    Miteva, Dimana
    Hughes, Christina
    Khan, Wasiulla
    Komrokji, Rami S.
    Garcia-Manero, Guillermo
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 142 - 143
  • [10] Transfusion Independence in Lower-Risk, Non-del5(q) Myelodysplastic Syndromes (LR-MDS) Among Patients (pts) Initiating Hypomethylating Agents (HMAs) While Receiving Red Blood Cell (RBC) Transfusions
    Zeidan, Amer M.
    Zhu, Weiwei
    Wang, Rong
    Stahl, Maximilian
    Huntington, Scott F.
    Giri, Smith
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Ma, Xiaomei
    Davidoff, Amy J.
    BLOOD, 2018, 132
12